Replimune Group, Inc. (REPL)
NASDAQ: REPL · Real-Time Price · USD
5.25
+0.26 (5.21%)
At close: Aug 12, 2025, 4:00 PM
5.10
-0.15 (-2.86%)
After-hours: Aug 12, 2025, 7:55 PM EDT
Paramount Global Market Cap
Replimune Group has a market cap or net worth of $409.79 million as of August 12, 2025. Its market cap has decreased by -42.77% in one year.
Market Cap
409.79M
Enterprise Value
82.78M
1-Year Change
-42.77%
Ranking
Category
Stock Price
$5.25
Market Cap Chart
Since July 20, 2018, Replimune Group's market cap has decreased from $467.51M to $409.79M, a decrease of -12.35%. That is a compound annual growth rate of -1.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2025 | 389.50M | -58.21% |
| Dec 31, 2024 | 931.93M | 87.18% |
| Dec 29, 2023 | 497.87M | -67.63% |
| Dec 30, 2022 | 1.54B | 21.04% |
| Dec 31, 2021 | 1.27B | -27.53% |
| Dec 31, 2020 | 1.75B | 245.20% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 20, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 561.67B |
| Johnson & Johnson | 417.44B |
| AbbVie | 349.87B |
| Abbott Laboratories | 233.71B |
| AstraZeneca | 227.85B |
| UnitedHealth Group | 227.59B |
| Novartis AG | 225.61B |
| Novo Nordisk | 224.34B |